, 2010). Heme mediates a feedback inhibition of the rate-limiting enzyme in the heme synthetic pathway, synthase of 5-aminolevulinic acid. It also reconstitutes heme stores and function of various hemoproteins, namely hemoglobin, cytochrome P450, guanylate synthase, nitric oxide synthases, tryptophan dioxygenase, catalase

and peroxidase. However, neither the exact pathogenesis of the neurovisceral symptoms in acute porphyrias, nor the precise mechanism of action of heme arginate are understood (http://www.porphyria.uct.ac.za/professional/prof-haem-therapy.htm; Herrick and McColl, 2005 and Siegesmund et al., 2010). Nevertheless since HA has been approved for human use, it can Veliparib mw be suggested that HA could be tested as a supplement of HAART in selected

cases. For example its administration could be suggested as an additional measure in early stages of HIV/AIDS disease to release the virus from the existing latent pool, while inhibiting its dissemination to the new viral reservoirs. Since the levels of TNF-α and other cytokines are increased and/or dysregulated in HIV/AIDS, HA might synergize with these cytokines in provirus reactivation also in vivo. The suggestion of HA use in HIV/AIDS is further supported by a case of an HIV-positive individual that was administered one infusion of Normosang because of anemia. This patient then remained p24 negative for several months Akt inhibitor (Pavel Martasek, General Faculty Hospital in Prague, Buspirone HCl personal communication). Obviously,

the use of HA should be tested first in animal models of retrovirus infection to assess its therapeutic potential against retroviruses more closely. Also, the administration of Normosang can be complicated by its adverse side effects. Vascular side effects of Normosang, especially on hemostasis, can occur, but they are reported to be much weaker than after administration of hematin (Panhaematin). Additionally, since hemin decreased HIV growth in humanized mice even when administered intraperitoneally ( Devadas and Dhawan, 2006), it is possible that the i.p. or some other way of administration of Normosang would be also effective against HIV in humans. Repeated administrations of HA could lead to an iron overload. However, HIV/AIDS disease is often accompanied by the anemia due to a chronic immune activation, altered porphyrin metabolism caused by iron deficiency ( Adetifa and Okomo, 2009 and Fuchs et al., 1990) as well as by treatment with antiretrovirals ( Bozzi et al., 2004 and Fox et al., 1999). All these conditions would be improved by the administration of heme, while iron overload might not develop. On the whole, these results suggest a possibility of an alternative approach to the management of HIV/AIDS disease.